Business Wire

NorthStar Medical Radioisotopes Now Routinely Manufacturing High Activity Copper-67 on its Electron Accelerators for Clarity Pharmaceuticals' Therapy Clinical Programs

BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC (“NorthStar"), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic ...
EurekAlert!

A new kind of copper from the research reactor

The copper isotope Cu-64 plays an important role in medicine: it is used in imaging processes and also shows potential for cancer therapy. However, it does not occur naturally and must be produced ...
Business Wire

First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic ...

BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC (“NorthStar"), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic ...
Healio

First patient dosed with electron accelerator-produced copper in neuroblastoma study

Please provide your email address to receive an email when new articles are posted on . The first patient has been dosed in a clinical trial with electron accelerator-produced Cu-67, according to a ...
BioWorld

Radiopharma Clarity touts advantages of its targeted copper theranostics

Clarity Pharmaceuticals Ltd. is progressing three of its targeted copper theranostics through the clinic that are based on its sarcophagine technology that securely holds copper isotopes inside a cage ...
CU Boulder News & Events

Front Range Isotope Day (FRIDay) 2023

The CU IsoBuffs - a loosely knit community of stable isotope enthusiasts at the University of Colorado - hosted the 2023 Front Range Isotope Day (FRIDay) on Friday August 25 th. The meeting was held ...